Between 2020 and 2025, we will rebuild all our 7 furnaces and upgrade them with new technologies (live monitoring systems, better thermal insulation, increased electric boosting). These improvements will eventually enable us to improve our overall energy efficiency by at least 7% by 2025.
SGD Pharma aims to reduce its CO 2 emissions by 5% per tons of goods produced. This equates to a saving of over 10,000 tons of CO 2 by 2025. We are planning to achieve this via:
Participation in FEVE Furnace of the Future Initiative:
We are one of 20 companies from the glass industry who have joined forces to create, fund and test a pilot furnace project. This will be the world’s first large-scale hybrid oxy-fuel furnace to run on 80% renewable electricity. This will replace current fossil-fuel energy sources and reduce CO 2 emissions by 50%.
